518 related articles for article (PubMed ID: 28774318)
1. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
[TBL] [Abstract][Full Text] [Related]
2. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Mbigha-Ghogomu S; Souopgui J; Zoure HG; Boussinesq M; Kamgno J; Robert A
Parasit Vectors; 2016 Nov; 9(1):581. PubMed ID: 27842567
[TBL] [Abstract][Full Text] [Related]
3. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
[TBL] [Abstract][Full Text] [Related]
4. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
[TBL] [Abstract][Full Text] [Related]
5. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
6. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
[TBL] [Abstract][Full Text] [Related]
7. Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.
Samuel A; Belay T; Yehalaw D; Taha M; Zemene E; Zeynudin A
PLoS One; 2016; 11(3):e0141029. PubMed ID: 26942910
[TBL] [Abstract][Full Text] [Related]
8. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
[TBL] [Abstract][Full Text] [Related]
9. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
10. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
[TBL] [Abstract][Full Text] [Related]
11. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
[TBL] [Abstract][Full Text] [Related]
12. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
[TBL] [Abstract][Full Text] [Related]
14. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
[TBL] [Abstract][Full Text] [Related]
15. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
[TBL] [Abstract][Full Text] [Related]
16. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
17. Parasitological indicators of onchocerciasis relevant to ivermectin control programmes in the Amazonian focus of Southern Venezuela.
Vivas-Martínez S; Basáñez MG; Botto C; Villegas L; García M; Curtis CF
Parasitology; 2000 Nov; 121 Pt 5():527-34. PubMed ID: 11128804
[TBL] [Abstract][Full Text] [Related]
18. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
[TBL] [Abstract][Full Text] [Related]
19. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
20. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
